What is the Future of Dendritic Cell Vaccines in Cancer Treatment?
Research is ongoing to improve the efficacy and accessibility of dendritic cell vaccines. Advances in genomics and proteomics are helping to identify new cancer antigens, while innovations in biotechnology are streamlining the production process. Combining dendritic cell vaccines with other forms of immunotherapy, such as checkpoint inhibitors, is also being explored to enhance their effectiveness.
